ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

PP2 alleviates the progression of osteoarthritis by inhibiting Wnt/β-catenin and activating TGF-β/Smad signaling

Zhang, Hao; Zheng, Chuanchuan; Chen, Wei; Li, Xiaoqiang; Wang, Jinshu; Wang, Taikun; Zhao, Qi; Huang, Hao; Li, Yiting; Yang, Chengliang; Xie, Kegong; Pan, Shengcai; Wang, Binghao; Wang, Chong; Tang, Yujin*; Li, Kai*; Liu, Jia*; Wang, Liqiang东莞理工学院; 南方医科大学; 上海交通大学
International Immunopharmacology2023-11DOI: 10.1016/j.intimp.2023.110948
5阅读
引用收藏
分享

摘要

Objective: We aimed to explore the effect and mechanism of the Src inhibitor PP2 on osteoarthritis (OA) progression.Methods: The protein expressions of Src, p-Src (y418) and p-FAK in normal and OA human chondrocytes were detected by immunofluorescence (IF) analysis. Chondrocytes from the femur and tibial plateau of 3-day-old mice were extracted and inoculated into 6-well plates. The chondrocytes were co-cultured with IL-1 beta and different doses of PP2, and then the degeneration of extracellular matrix was analyzed. A mouse OA model was induced by destabilizing medial meniscectomy of the right knee. Two weeks after the operation, different doses of PP2 were injected intraperitoneally. The drug was given three times a week for 6 weeks, and then the mice were sacrificed. Histopathological, IF and immunoblotting analyses were used to detect key OA catabolic markers and protein expression and related signaling.Results: The levels of Src, p-Src (y418) and p-FAK in the knee cartilage tissue of patients with OA were abnormally increased. After chondrocytes were co-treated with IL-1 beta and different doses of PP2, the results showed that PP2 reduced the abnormal increase of beta-catenin, p-beta-catenin and other proteins induced by IL-1 beta, and reversed the decrease of p-Smad3, aggrecan and collagen II protein levels. Meanwhile, intraperitoneal injection of PP2 in vivo significantly reduced the degeneration of articular cartilage in the OA mouse model.Conclusion: Our data indicate that targeting Src with PP2 protected against cartilage destruction in an OA mouse model by inhibiting Wnt/beta-catenin and activating TGF-beta/Smad signaling, suggesting that Src may be a potential therapeutic target for OA treatment.

学科与关键词

关键词
OsteoarthritisPP2SrcWnt/beta-catenin signalingTGF-beta/Smad signaling
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
International Immunopharmacology
发表日期
2023-11
卷期
第 124 卷
页码
110948
DOI
10.1016/j.intimp.2023.110948
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of China [32160209, 82160357, 82071361]; Guangxi Key Laboratory of basic and translational research of Bone and Joint Degenerative Diseases, China [21-220-06]

作者

  • Z

    Zhang, Hao (第一作者)

    youjiang med univ nationalities

  • Z

    Zheng, Chuanchuan

    youjiang med univ nationalities

查看全部 18 位作者收起作者
  • C

    Chen, Wei

    youjiang med univ nationalities

  • L

    Li, Xiaoqiang

    youjiang med univ nationalities

  • W

    Wang, Jinshu

    youjiang med univ nationalities

  • W

    Wang, Taikun

    youjiang med univ nationalities

  • Z

    Zhao, Qi

    youjiang med univ nationalities

  • H

    Huang, Hao

    youjiang med univ nationalities

  • L

    Li, Yiting

    youjiang med univ nationalities

  • Y

    Yang, Chengliang

    youjiang med univ nationalities

  • X

    Xie, Kegong

    youjiang med univ nationalities

  • P

    Pan, Shengcai

    youjiang med univ nationalities

  • W

    Wang, Binghao

    youjiang med univ nationalities

  • W

    Wang, Chong

    dongguan univ technol

  • T

    Tang, Yujin (通讯)

    youjiang med univ nationalities

  • L

    Li, Kai (通讯)

    southern med univ

  • L

    Liu, Jia (通讯)

    youjiang med univ nationalities

  • W

    Wang, Liqiang

    shanghai jiao tong univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417